Environment

Joint statement from the human pharmaceutical industry on the Urban Wastewater Treatment Directive (2024) View
Environment

Joint statement from the human pharmaceutical industry on the Urban Wastewater Treatment Directive (2024)

Read more
AESGP feedback on the Proposal for a Green Claims Directive (2023) View
Environment

AESGP feedback on the Proposal for a Green Claims Directive (2023)

Read more
AESGP Reply to the Feedback Procedure on the Commission's Proposal for a Regulation on Packaging and Packaging Waste (2023) View
Environment

AESGP Reply to the Feedback Procedure on the Commission's Proposal for a Regulation on Packaging and Packaging Waste (2023)

Read more
Joint Statement on the Packaging and Packaging Waste Regulation's Single Market Legal Basis (2023) View
Environment

Joint Statement on the Packaging and Packaging Waste Regulation's Single Market Legal Basis (2023)

Read more
White Paper “Balancing challenges on Environment with access to medicines in Europe”: Impact assessment of policy options for Pharmaceuticals in the Environment and the use of Extended Producer Responsibility applied to human medicines (2023) View
Environment

White Paper “Balancing challenges on Environment with access to medicines in Europe”: Impact assessment of policy options for Pharmaceuticals in the Environment and the use of Extended Producer Responsibility applied to human medicines (2023)

Read more
AESGP feedback on the Proposal for a Directive amending the Water Framework Directive, Groundwater Directive, and Environmental Quality Standards Directive (2023) View
Environment

AESGP feedback on the Proposal for a Directive amending the Water Framework Directive, Groundwater Directive, and Environmental Quality Standards Directive (2023)

Read more
Extended Environmental Risk Assessment (eERA) proposal: Proactively managing the environmental risks associated with the patient use of human medicinal products (2023) View
Environment

Extended Environmental Risk Assessment (eERA) proposal: Proactively managing the environmental risks associated with the patient use of human medicinal products (2023)

Read more
Technical Guidance on Responsible Manufacturing Effluent Management (2023) View
Environment

Technical Guidance on Responsible Manufacturing Effluent Management (2023)

Read more
AESGP Position Paper on the revision on Urban Waste Water Treatment Directive (2023) View
Environment

AESGP Position Paper on the revision on Urban Waste Water Treatment Directive (2023)

Read more
Joint Statement on the Urban Waste Water Treatment Directive Proposal (2022) View
Environment

Joint Statement on the Urban Waste Water Treatment Directive Proposal (2022)

Read more
Inter-Association Policy Statement on Responsible Manufacturing Effluent Management (2022) View
Environment

Inter-Association Policy Statement on Responsible Manufacturing Effluent Management (2022)

Read more
Eco-Pharmaco-Stewardship (EPS) Brochure (2022) View
Environment

Eco-Pharmaco-Stewardship (EPS) Brochure (2022)

Read more
AESGP pledge to GSCF’s Charter for Environmentally Sustainable Self-Care (2021) View
Environment

AESGP pledge to GSCF’s Charter for Environmentally Sustainable Self-Care (2021)

Read more
European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment View
Environment

European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment

Read more
EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment View
Environment

EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment

Read more